한글목차

유방 조직 마커 시장 규모는 최근, 현저한 성장을 달성하고 있습니다. 2025년 29억 9,000만 달러에서 2026년에는 32억 4,000만 달러로, CAGR 8.5%로 확대가 전망되고 있습니다. 지난 수년간의 성장 요인으로는 조직 마커 재료의 구하기 어려움, 기존 금속 마커에 대한 의존도, 유방암 진단율 증가, 병원 및 수술센터에서의 채용 확대, 정확한 생검 부위 식별에 대한 수요 증가 등을 들 수 있습니다.

유방 조직 마커 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2030년에는 44억 3,000만 달러에 달하며, CAGR은 8.2%에 달할 전망입니다. 예측 기간 중의 성장 요인으로는 폴리머 기반 및 젤라틴 마커의 개발, 최소침습적 생검 기술의 확대, 영상 진단용 조직 마커에 대한 투자 증가, 환자 안전 및 마커의 생체 적합성에 대한 인식 증가, 조직 마커와 첨단 영상 진단 시스템과의 통합 등이 있습니다. 예측 기간 중 주요 동향으로는 금속 및 비금속 조직 마커의 채택 증가, 생분해성 및 방사선 불투과성 마커에 대한 선호도 증가, 유방암 검진 및 생검 절차 증가, 정확한 위치 파악을 위한 형상 특이적 마커에 대한 수요, 영상 진단과의 호환성 및 환자 안전에 대한 관심 강화 등이 있습니다. 등을 들 수 있습니다.

유방암 환자 증가는 향후 유방 조직 마커 시장의 성장을 지원할 것으로 예측됩니다. 유방암은 유방 조직의 세포에서 발생하는 악성 종양입니다. 유방암 사례 증가는 일반적으로 평균 수명의 연장, 진단 방법의 발전, 라이프스타일의 변화, 환경적 요인 등의 요소와 관련이 있습니다. 유방 조직 마커는 특정 단백질이나 유전자 변이를 확인함으로써 유방암 치료에서 진단 지원, 질병 진행 모니터링, 치료 방침 결정의 지침으로 활용됩니다. 예를 들어 미국 비영리단체 Breastcancer.org의 10월 보고서에 따르면 2025년에는 약 31만 6,950명의 여성이 침윤성 유방암 진단을 받을 것으로 추정되며, 약 5만 9,080건의 비침윤성 유관상피내암(DCIS) 신규 사례가 보고될 것으로 예측됩니다. 보고될 것으로 예측됩니다. 그 결과, 유방암 환자 수 증가는 유방 조직 마커 시장의 성장 전망을 강화시키고 있습니다.

유방 조직 마커 시장에서 활동하는 주요 기업은 초음파 가시성 향상, 위치 확인 용이성 개선, 수술 중 위치 오차를 줄이기 위한 유방 생검 부위 마커와 같은 혁신적인 솔루션 개발에 주력하고 있습니다. 유방 생검 부위 마커는 향후 영상 진단이나 수술시 위치를 표시하기 위해 생검 부위에 삽입하는 소형 임플란트 장치입니다. 예를 들어 2023년 8월, 미국에 본사를 둔 유방 생검 마커 공급업체인 Mammotome은 HydroMARK Plus 유방 생검 부위 마커를 발표했습니다. 이 마커는 체액과 접촉하면 팽창하는 하이드로겔 디자인을 채택하여 초음파에 의한 가시성을 크게 향상시킵니다. 이 디자인은 정확한 부위 마킹과 후속 진단 및 치료 시술을 위한 정확한 위치 파악을 지원하며, 유방 조직 내에서 장기적인 안정성을 제공하여 재시술의 필요성을 줄여줍니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 용도 산업의 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장의 세계 TAM(Total Addressable Market)

제9장 시장 세분화

제10장 지역별·국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 대기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 합병과 인수

제40장 시장의 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

Breast tissue markers are small implanted devices used in breast cancer diagnosis and treatment to mark the location of a biopsy site, tumor, or suspicious area within the breast. They are typically placed during biopsy procedures to allow accurate identification of the site during future imaging, surgery, or treatment.

The main product types of breast tissue markers include metal and non-metal markers. Metal breast tissue markers are small metallic markers, commonly made of materials such as stainless steel, used to accurately locate and monitor breast tumors. The materials include non-biodegradable and partially biodegradable options, and the shapes include coil, ribbon, butterfly, V-shape, and others. These markers are used by end users such as hospitals, ambulatory surgical centers, diagnostic centers, and specialty clinics.

Tariffs are impacting the breast tissue markers market by increasing the cost of imported metals such as titanium, stainless steel, and gold, as well as specialized polymers used in non-metal markers. Segments like metal markers and polymer-based markers are most impacted, particularly in regions like Asia-Pacific and North America. While tariffs have raised production and supply costs, they have also encouraged domestic manufacturing, innovation in biodegradable markers, and the development of cost-efficient alternatives, strengthening local capabilities over time.

The breast tissue markers market research report is one of a series of new reports from The Business Research Company that provides breast tissue markers market statistics, including breast tissue markers industry global market size, regional shares, competitors with a breast tissue markers market share, detailed breast tissue markers market segments, market trends and opportunities, and any further data you may need to thrive in the breast tissue markers industry. This breast tissue markers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The breast tissue markers market size has grown strongly in recent years. It will grow from $2.99 billion in 2025 to $3.24 billion in 2026 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to limited availability of tissue marker materials, reliance on traditional metallic markers, growing breast cancer diagnosis rates, increasing hospital and surgical center adoption, demand for accurate biopsy site localization.

The breast tissue markers market size is expected to see strong growth in the next few years. It will grow to $4.43 billion in 2030 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to development of polymer-based and gelatin markers, expansion of minimally invasive biopsy procedures, rising investment in imaging-compatible tissue markers, increasing awareness of patient safety and marker biocompatibility, integration of tissue markers with advanced imaging systems. Major trends in the forecast period include increasing adoption of metal and non-metal tissue markers, rising preference for biodegradable and radiopaque markers, growth in breast cancer screening and biopsy procedures, demand for shape-specific markers for accurate localization, enhanced focus on imaging compatibility and patient safety.

The rise in the number of breast cancer cases is anticipated to support the expansion of the breast tissue markers market going forward. Breast cancer is a malignant tumor that originates in the cells of breast tissue. The increase in breast cancer cases is commonly associated with factors such as increased life expectancy, advancements in diagnostic methods, lifestyle changes, and environmental influences. Breast tissue markers are utilized in breast cancer care to assist in diagnosis, monitor disease progression, and guide treatment decisions by identifying specific proteins or genetic mutations. For example, in October 2025, according to Breastcancer.org, a US-based non-profit organization, it was reported that in 2025 an estimated 316,950 women are expected to be diagnosed with invasive breast cancer, along with approximately 59,080 new cases of non-invasive ductal carcinoma in situ (DCIS). Consequently, the rising number of breast cancer cases is strengthening the growth outlook of the breast tissue markers market.

Leading companies operating in the breast tissue markers market are focusing on developing innovative solutions, such as breast biopsy site markers, to enhance ultrasound visibility, improve ease of localization, and reduce displacement during surgical procedures. A breast biopsy site marker is a small implantable device placed at the biopsy site to mark the location for future imaging or surgical intervention. For example, in August 2023, Mammotome, a US-based provider of breast biopsy markers, introduced the HydroMARK Plus breast biopsy site marker. This marker incorporates a hydrogel design that expands upon contact with fluid, significantly enhancing ultrasound visibility. Its design supports accurate site marking and reliable localization for follow-up diagnostic and treatment procedures, while providing long-term stability within breast tissue and reducing the need for repeat interventions.

In July 2024, Hologic Inc., a US-based health technology company, acquired Endomagnetics Ltd. for an undisclosed amount. This acquisition enables Hologic to expand its breast cancer diagnostics and treatment portfolio by integrating Endomagnetics' advanced magnetic detection technologies. Endomagnetics Ltd. is a UK-based provider of breast tissue marker technologies.

Major companies operating in the breast tissue markers market are Johnson & Johnson Company, Medtronic PLC, Hologic Inc., Cook Medical Inc., Merit Medical Systems Inc., Argon Medical Devices Inc., Devicor Medical Products Inc., Endomag, Becton Dickinson and Company, INRAD Inc., Biopsy Sciences LLC, Carbon Medical Technologies Inc., Scion Medical Technologies LLC, SOMATEX Medical Technologies GmbH, Seno Medical Instruments Inc, Sterylab S.r.l., Biopsybell S.r.l., MDL S.r.l., SenoRx Inc, Elucent Medical, Cortex, Medax Medical Devices, Tsunami S.r.l., Ranfac Corp

North America was the largest region in the breast tissue markers market in 2025. The regions covered in the breast tissue markers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the breast tissue markers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The breast tissue markers consist of sales of radiofrequency identification (RFID) markers, magnetic markers, ultrasound-visible markers, and hydrogel markers. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Breast Tissue Markers Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses breast tissue markers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for breast tissue markers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The breast tissue markers market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product: Metal; Non-metal
• 2) By Material: Non-biodegradable; Partially Biodegradable
• 3) By Shape: Coil; Ribbon; Butterfly; V-Shape; Other Shapes
• 4) By End-user: Hospitals; Ambulatory; Surgical Centers; Diagnostic Centers; Specialty Clinics
• Subsegments:
• 1) By Metal: Titanium Markers; Stainless Steel Markers; Gold Markers
• 2) By Non-Metal: Biodegradable Markers; Radiopaque Markers; Polymer-Based Markers; Gelatin Markers
• Companies Mentioned: Johnson & Johnson Company; Medtronic PLC; Hologic Inc.; Cook Medical Inc.; Merit Medical Systems Inc.; Argon Medical Devices Inc.; Devicor Medical Products Inc.; Endomag; Becton Dickinson and Company; INRAD Inc.; Biopsy Sciences LLC; Carbon Medical Technologies Inc.; Scion Medical Technologies LLC; SOMATEX Medical Technologies GmbH; Seno Medical Instruments Inc; Sterylab S.r.l.; Biopsybell S.r.l.; MDL S.r.l.; SenoRx Inc; Elucent Medical; Cortex; Medax Medical Devices; Tsunami S.r.l.; Ranfac Corp
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Breast Tissue Markers Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Breast Tissue Markers Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Breast Tissue Markers Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Breast Tissue Markers Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.3 Industry 4.0 & Intelligent Manufacturing
  • 4.1.4 Artificial Intelligence & Autonomous Intelligence
  • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 Increasing Adoption Of Metal And Non-Metal Tissue Markers
  • 4.2.2 Rising Preference For Biodegradable And Radiopaque Markers
  • 4.2.3 Growth In Breast Cancer Screening And Biopsy Procedures
  • 4.2.4 Demand For Shape-Specific Markers For Accurate Localization
  • 4.2.5 Enhanced Focus On Imaging Compatibility And Patient Safety

5. Breast Tissue Markers Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Ambulatory Surgical Centers
• 5.3 Diagnostic Centers
• 5.4 Specialty Clinics
• 5.5 Oncology Centers

6. Breast Tissue Markers Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Breast Tissue Markers Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Breast Tissue Markers PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Breast Tissue Markers Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Breast Tissue Markers Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Breast Tissue Markers Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Breast Tissue Markers Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Breast Tissue Markers Market Segmentation

• 9.1. Global Breast Tissue Markers Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Metal, Non-metal
• 9.2. Global Breast Tissue Markers Market, Segmentation By Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Non-biodegradable, Partially Biodegradable
• 9.3. Global Breast Tissue Markers Market, Segmentation By Shape, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Coil, Ribbon, Butterfly, V-Shape, Other Shapes
• 9.4. Global Breast Tissue Markers Market, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals, Ambulatory, Surgical Centers, Diagnostic Centers, Specialty Clinics
• 9.5. Global Breast Tissue Markers Market, Sub-Segmentation Of Metal, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Titanium Markers, Stainless Steel Markers, Gold Markers
• 9.6. Global Breast Tissue Markers Market, Sub-Segmentation Of Non-Metal, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Biodegradable Markers, Radiopaque Markers, Polymer-Based Markers, Gelatin Markers

10. Breast Tissue Markers Market Regional And Country Analysis

• 10.1. Global Breast Tissue Markers Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Breast Tissue Markers Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Breast Tissue Markers Market

• 11.1. Asia-Pacific Breast Tissue Markers Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Breast Tissue Markers Market, Segmentation By Product, Segmentation By Material, Segmentation By Shape, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Breast Tissue Markers Market

• 12.1. China Breast Tissue Markers Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Breast Tissue Markers Market, Segmentation By Product, Segmentation By Material, Segmentation By Shape, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Breast Tissue Markers Market

• 13.1. India Breast Tissue Markers Market, Segmentation By Product, Segmentation By Material, Segmentation By Shape, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Breast Tissue Markers Market

• 14.1. Japan Breast Tissue Markers Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Breast Tissue Markers Market, Segmentation By Product, Segmentation By Material, Segmentation By Shape, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Breast Tissue Markers Market

• 15.1. Australia Breast Tissue Markers Market, Segmentation By Product, Segmentation By Material, Segmentation By Shape, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Breast Tissue Markers Market

• 16.1. Indonesia Breast Tissue Markers Market, Segmentation By Product, Segmentation By Material, Segmentation By Shape, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Breast Tissue Markers Market

• 17.1. South Korea Breast Tissue Markers Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Breast Tissue Markers Market, Segmentation By Product, Segmentation By Material, Segmentation By Shape, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Breast Tissue Markers Market

• 18.1. Taiwan Breast Tissue Markers Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Breast Tissue Markers Market, Segmentation By Product, Segmentation By Material, Segmentation By Shape, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Breast Tissue Markers Market

• 19.1. South East Asia Breast Tissue Markers Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Breast Tissue Markers Market, Segmentation By Product, Segmentation By Material, Segmentation By Shape, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Breast Tissue Markers Market

• 20.1. Western Europe Breast Tissue Markers Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Breast Tissue Markers Market, Segmentation By Product, Segmentation By Material, Segmentation By Shape, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Breast Tissue Markers Market

• 21.1. UK Breast Tissue Markers Market, Segmentation By Product, Segmentation By Material, Segmentation By Shape, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Breast Tissue Markers Market

• 22.1. Germany Breast Tissue Markers Market, Segmentation By Product, Segmentation By Material, Segmentation By Shape, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Breast Tissue Markers Market

• 23.1. France Breast Tissue Markers Market, Segmentation By Product, Segmentation By Material, Segmentation By Shape, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Breast Tissue Markers Market

• 24.1. Italy Breast Tissue Markers Market, Segmentation By Product, Segmentation By Material, Segmentation By Shape, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Breast Tissue Markers Market

• 25.1. Spain Breast Tissue Markers Market, Segmentation By Product, Segmentation By Material, Segmentation By Shape, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Breast Tissue Markers Market

• 26.1. Eastern Europe Breast Tissue Markers Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Breast Tissue Markers Market, Segmentation By Product, Segmentation By Material, Segmentation By Shape, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Breast Tissue Markers Market

• 27.1. Russia Breast Tissue Markers Market, Segmentation By Product, Segmentation By Material, Segmentation By Shape, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Breast Tissue Markers Market

• 28.1. North America Breast Tissue Markers Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Breast Tissue Markers Market, Segmentation By Product, Segmentation By Material, Segmentation By Shape, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Breast Tissue Markers Market

• 29.1. USA Breast Tissue Markers Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Breast Tissue Markers Market, Segmentation By Product, Segmentation By Material, Segmentation By Shape, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Breast Tissue Markers Market

• 30.1. Canada Breast Tissue Markers Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Breast Tissue Markers Market, Segmentation By Product, Segmentation By Material, Segmentation By Shape, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Breast Tissue Markers Market

• 31.1. South America Breast Tissue Markers Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Breast Tissue Markers Market, Segmentation By Product, Segmentation By Material, Segmentation By Shape, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Breast Tissue Markers Market

• 32.1. Brazil Breast Tissue Markers Market, Segmentation By Product, Segmentation By Material, Segmentation By Shape, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Breast Tissue Markers Market

• 33.1. Middle East Breast Tissue Markers Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Breast Tissue Markers Market, Segmentation By Product, Segmentation By Material, Segmentation By Shape, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Breast Tissue Markers Market

• 34.1. Africa Breast Tissue Markers Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Breast Tissue Markers Market, Segmentation By Product, Segmentation By Material, Segmentation By Shape, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Breast Tissue Markers Market Regulatory and Investment Landscape

36. Breast Tissue Markers Market Competitive Landscape And Company Profiles

• 36.1. Breast Tissue Markers Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Breast Tissue Markers Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Breast Tissue Markers Market Company Profiles
  • 36.3.1. Johnson & Johnson Company Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Cook Medical Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Merit Medical Systems Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Breast Tissue Markers Market Other Major And Innovative Companies

• Argon Medical Devices Inc., Devicor Medical Products Inc., Endomag, Becton Dickinson and Company, INRAD Inc., Biopsy Sciences LLC, Carbon Medical Technologies Inc., Scion Medical Technologies LLC, SOMATEX Medical Technologies GmbH, Seno Medical Instruments Inc, Sterylab S.r.l., Biopsybell S.r.l., MDL S.r.l., SenoRx Inc, Elucent Medical

38. Global Breast Tissue Markers Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Breast Tissue Markers Market

40. Breast Tissue Markers Market High Potential Countries, Segments and Strategies

• 40.1 Breast Tissue Markers Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Breast Tissue Markers Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Breast Tissue Markers Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer